mybacs Company

Mybacs is a biotechnology company that specializes in the human microbiome and aims to revolutionize the market around intestinal healthcare. The company develops innovative and highly-dosed synbiotic supplements tailored to the individual needs of their customers. Mybacs is a research-driven company with a team of pharmaceutical scientists and physicians. They are a DTC company that focuses on the daily well-being of their customers.


Headquarters: Baar, Zug, Switzerland
Industry: Wellness & Fitness
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 2
Investor Type: For Profit
Funding Status: Seed
Technology: Nutrition
Last Funding Type: Series A
Founded Date: 2019-01-01
Total Funding: $5.4M